Arthritis, lupus, vasculitis, biologics, and immune‑modulating therapies.
An article joins this feed when it matches these terms. Each one is also a search of its own.
Granulomatosis with polyangiitis (GPA) is a systemic necrotizing granulomatous vasculitis classically involving the upper and lower respiratory tracts and kidneys. Timely diagnosis requires a high index of suspicion for the presenting symptoms. Otolaryngologic manifestations are commonly reported but most often…
Presented by AJMC and Pharmacy Times Population Health, Equity & Outcomes Objectives: To examine demographic and clinical characteristics of first-time Medicare Advantage (MA) enrollees between 2012 and 2022 and to better understand changes in this population as it has grown. Study Design: We…
A large-scale serology study presented at UEG Week 2026 found distinct antibody signatures up to ten years before an inflammatory bowel disease diagnosis, with machine-learning models achieving strong discrimination for Crohn's disease and ulcerative colitis.
A senior federal health official has acknowledged that Medicare's experiment with AI-assisted prior authorization is falling short. "There are a lot of things about WISeR that are not working," Centers for Medicare & Medicaid Services (CMS) Deputy Administrator Kimberly Brandt said…
A longitudinal study of 155 lymphoma patients found that older adults recovered memory function after CAR T-cell therapy while younger adults showed unexpected cognitive vulnerability. Chimeric antigen receptor T-cell therapy has transformed the outlook for patients with large B-cell lymphoma whose…
Chimeric antigen receptor T cell therapy has redefined the treatment of multiple myeloma, offering deep and durable remissions to patients whose disease had resisted every conventional option.
Read:2027 Social Security COLA is announced; it’s big but is it enough?Discover:How to Navigate Your Medicare Options for Retirement Medicare Advantage, also referred to as Part C, is an alternative to Original Medicare. In addition to providing hospitalization…
Bioengineer.org Subject of Research: Immunology News Source: Ophelia Keating. (October 18, 2026). FAS and FASL Blood Tests Fall Short as Diagnostic Biomarkers for Autoimmune Lymphoproliferative Syndrome. Scienmag.
Addressing Unmet Need in AIHA Through B Cell Targeting AIHA is an autoimmune disorder characterized by excessive, autoantibody-mediated destruction of red blood cells. Symptoms may include anemia, fatigue and shortness of breath, and severe cases can be life-threatening. Some patients…
Deadline: December 7, 2026 Don't Wait! Open Enrollment runs October 15 to December 7. A little homework now can save you serious money (and spare you a penalty that sticks around for life). Turning 65 comes with some real perks. (Senior discounts! Fewer fashion rules!)…